刚开始
发表于 2025-3-23 09:59:11
http://reply.papertrans.cn/59/5891/589081/589081_11.png
Colonnade
发表于 2025-3-23 14:14:35
http://reply.papertrans.cn/59/5891/589081/589081_12.png
Ancestor
发表于 2025-3-23 18:38:46
http://reply.papertrans.cn/59/5891/589081/589081_13.png
Femish
发表于 2025-3-23 22:20:54
http://reply.papertrans.cn/59/5891/589081/589081_14.png
比赛用背带
发表于 2025-3-24 03:26:13
Personalized Therapy of Small Cell Lung Cancer,acteristics. Despite robust responses to initial chemotherapy and radiation, the prognosis of patients with SCLC remains poor with an overall 5-year survival rate of less than 10 %. Despite the fact that numerous molecularly targeted approaches have thus far failed to demonstrate clinical utility in
才能
发表于 2025-3-24 06:48:26
http://reply.papertrans.cn/59/5891/589081/589081_16.png
车床
发表于 2025-3-24 12:20:17
http://reply.papertrans.cn/59/5891/589081/589081_17.png
Breach
发表于 2025-3-24 18:12:23
https://doi.org/10.1007/978-3-319-24932-2Lung cancer; Genomics; Therapeutic Implications; Stem Cells; Small Cell Lung Cancer; Radiation Therapy
Comprise
发表于 2025-3-24 20:12:25
978-3-319-79702-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
Facet-Joints
发表于 2025-3-25 01:50:15
Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management978-3-319-24932-2Series ISSN 0065-2598 Series E-ISSN 2214-8019